New study aims to ease chronic pain in opioid recovery patients
NCT ID NCT06367387
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests two approaches to help people with opioid use disorder and chronic pain feel better. One is a pain self-management program with coaching and peer support. The other allows flexible dosing of buprenorphine based on pain levels. 268 adults from participating clinics will take part over 12 weeks, with follow-up surveys for a year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
buprenorphine (also known as Suboxone, Subutex, Zubsolv)
What this could lead to
If successful, this could offer a better way to manage chronic pain in people being treated for opioid addiction, potentially improving their quality of life and treatment retention.
What could go wrong
This is a Phase 4 study with 268 participants, so results may not apply to everyone. Risks include psychological distress from discussing pain and possible side effects from higher buprenorphine doses.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alcohol and Drug Abuse Program (ADAP) - UM Addiction Treatment Center
Baltimore, Maryland, 21223, United States
-
Central City Concern (CCC)
Portland, Oregon, 97209, United States
-
MATClinics
Dundalk, Maryland, 21222, United States
-
OHSU Harm Reduction Bridges to Care (HRBR)
Portland, Oregon, 97239, United States
-
OHSU Internal Medicine Clinic (IMC)
Portland, Oregon, 97239, United States
-
Recovery Works Northwest (RWNW)
Portland, Oregon, 97233, United States
-
UPMC Internal Medicine Recovery Engagement Program (IM-REP)
Pittsburgh, Pennsylvania, 15219, United States
-
UPMC Latterman Family Health Center
McKeesport, Pennsylvania, 15132, United States
-
UPMC Magee-Womens Pregnancy and Women's Recovery Center (PWRC)
Pittsburgh, Pennsylvania, 15213, United States
-
UPMC St. Margaret Family Health Center
New Kensington, Pennsylvania, 15068, United States
-
WVU Chestnut Ridge Comprehensive Addiction Treatment Program (COAT)
Morgantown, West Virginia, 26505, United States
-
WVU Crisis Support & Recovery Center
Martinsburg, West Virginia, 25401, United States
-
Wells House
Hagerstown, Maryland, 21740, United States